GlassScriptPhysician profile
Larry S Janoff
NPI 1245200864
$2,427.95
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $469.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $599.53 | 2019-2020 | |
| Emd Serono, INC. | $400.20 | 2019-2020 | |
| Genzyme Corporation | $196.42 | 2019 | |
| Kyowa Kirin, INC. | $144.61 | 2020 | |
| Novartis Pharmaceuticals Corporation | $116.51 | 2019 | |
| Amneal Pharmaceuticals LLC | $84.30 | 2019 | |
| Genentech USA, INC. | $81.90 | 2019-2020 | |
| Lilly USA, LLC | $74.78 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $71.81 | 2019 | |
| Acorda Therapeutics, INC | $69.98 | 2019 | |
| Greenwich Biosciences, INC. | $59.80 | 2019 | |
| Amgen INC. | $59.20 | 2019-2020 | |
| Abbvie INC. | $55.89 | 2019 | |
| Supernus Pharmaceuticals, INC. | $52.61 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $42.29 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $40.42 | 2019 | |
| Avanir Pharmaceuticals, INC. | $40.20 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $38.95 | 2019 | |
| Mallinckrodt Enterprises LLC | $30.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Adamas Pharmaceuticals, INC. | $25.77 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.35 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $22.53 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.79 | 2019 | |
| Currax Pharmaceuticals LLC | $13.78 | 2020 | |
| Shire North American Group INC | $13.64 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.51 | 2019 | |
| Allergan, INC. | $10.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Janoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.